Substance / Medication

Ethanoic acid

Overview

Active Ingredient
acetic acid
RxNorm CUI
168

Indications

For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation.

Labeler: Sun Pharmaceutical Industries, Inc.Updated: 2025-07-07T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

Hypersensitivity to hydrocortisone and acetic acid otic solution or any of the ingredients; herpes simplex, vaccinia and varicella. Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

27 trials linked to this intervention

27
Total Trials
4
Recruiting
5
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Novel three-dimensional coordination polymer of 2-(1,3,5-tri-aza-7-phospho-niatri-cyclo-[3.3.1.1]decan-7-yl)ethanoic acid with silver(I) tetra-fluoro-borate.
Udvardy Antal, Kathó Ágnes, Papp Gábor et al. · Acta Crystallogr E Crystallogr Commun · 2022
PMID: 35371541OtherFull text (PMC)
Silylpyrrole Oxidation En Route to Saxitoxin Congeners Including 11-Saxitoxinethanoic Acid.
Tang Doris T Y, Merit Jeffrey E, Bedell T Aaron et al. · J Org Chem · 2021
PMID: 34874731OtherFull text (PMC)
Divergent Synthesis of Natural Derivatives of (+)-Saxitoxin Including 11-Saxitoxinethanoic Acid.
Walker James R, Merit Jeffrey E, Thomas-Tran Rhiannon et al. · Angew Chem Int Ed Engl · 2019
PMID: 30488599OtherFull text (PMC)
A Direct C11 Alkylation Strategy on the Saxitoxin Core: A Synthesis of (+)-11-Saxitoxinethanoic Acid.
Paladugu Srinivas R, James Chintelle K, Looper Ryan E · Org Lett · 2019
PMID: 31553620OtherFull text (PMC)
Carboxylic acid-capped ruthenium nanoparticles: experimental and theoretical case study with ethanoic acid.
González-Gómez Roberto, Cusinato Lucy, Bijani Christian et al. · Nanoscale · 2019
PMID: 31038521Other
Metabolism of Cyanide by Glutathione To Produce the Novel Cyanide Metabolite 2-Aminothiazoline-4-oxoaminoethanoic Acid.
Gyamfi Obed A, Bortey-Sam Nesta, Mahon Sari B et al. · Chem Res Toxicol · 2019
PMID: 30724077Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Acetic acid (substance)
SNOMED CT
2869004
UMLS CUI
C0000983
RxNorm CUI
168
Labeler
Sun Pharmaceutical Industries, Inc.

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
27
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.